Paola S. Dal Cin
Medical Genetics
75 Francis St
Bwh, Department Of Pathology
Boston, MA 02115
Bwh, Department Of Pathology
Boston, MA 02115
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Strategies for identifying NUP98 rearrangements in adult myeloid neoplasms.
Journal: Haematologica
Published: April 22, 2025
Odontogenic Myxoma Harbors Widespread Loss of Heterozygosity and Not Trisomies.
Journal: The American journal of surgical pathology
Published: March 12, 2025
Erythroblastic Sarcoma in Adults and Children: Different Pathways to the Same Destination.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 10, 2024
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
Journal: American journal of hematology
Published: December 11, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Journal: Science translational medicine
Published: September 20, 2023
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.
Journal: JCO oncology practice
Published: September 08, 2023
Inflammatory and Nested Testicular Sex Cord Tumor: A Novel Neoplasm With Aggressive Clinical Behavior and Frequent EWSR1::ATF1 Gene Fusions.
Journal: The American journal of surgical pathology
Published: February 15, 2023
Low-grade Fibromyxoid Sarcoma of the Vulva and Vagina: Clinical, Pathologic, and Molecular Characterization of 7 Cases and Review of the Literature.
Journal: The American journal of surgical pathology
Published: May 26, 2022
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Journal: Blood
Published: May 03, 2022
Guiding the global evolution of cytogenetic testing for hematologic malignancies.
Journal: Blood
Published: October 03, 2021
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
Journal: Blood advances
Published: September 23, 2021
Last Updated: 09/26/2026